Suppr超能文献

内源性纤维蛋白溶解在血小板血栓形成中的重要性。

Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation.

作者信息

Gue Ying X, Gorog Diana A

机构信息

Department of Cardiology, East and North Hertfordshire NHS Trust, Hertfordshire SG1 4AB, UK.

Department of Postgraduate Medicine, University of Hertfordshire, Hertfordshire AL10 9AB, UK.

出版信息

Int J Mol Sci. 2017 Aug 25;18(9):1850. doi: 10.3390/ijms18091850.

Abstract

The processes of thrombosis and coagulation are finely regulated by endogenous fibrinolysis maintaining healthy equilibrium. When the balance is altered in favour of platelet activation and/or coagulation, or if endogenous fibrinolysis becomes less efficient, pathological thrombosis can occur. Arterial thrombosis remains a major cause of morbidity and mortality in the world despite advances in medical therapies. The role endogenous fibrinolysis in the pathogenesis of arterial thrombosis has gained increasing attention in recent years as it presents novel ways to prevent and treat existing diseases. In this review article, we discuss the role of endogenous fibrinolysis in platelet thrombus formation, methods of measurement of fibrinolytic activity, its role in predicting cardiovascular diseases and clinical outcomes and future directions.

摘要

血栓形成和凝血过程受到内源性纤维蛋白溶解的精细调节,以维持健康的平衡。当平衡向有利于血小板活化和/或凝血的方向改变时,或者如果内源性纤维蛋白溶解效率降低,就会发生病理性血栓形成。尽管医学治疗取得了进展,但动脉血栓形成仍然是全球发病和死亡的主要原因。近年来,内源性纤维蛋白溶解在动脉血栓形成发病机制中的作用越来越受到关注,因为它为预防和治疗现有疾病提供了新的途径。在这篇综述文章中,我们讨论了内源性纤维蛋白溶解在血小板血栓形成中的作用、纤维蛋白溶解活性的测量方法、其在预测心血管疾病和临床结果中的作用以及未来的方向。

相似文献

1
Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation.
Int J Mol Sci. 2017 Aug 25;18(9):1850. doi: 10.3390/ijms18091850.
4
Endogenous Fibrinolysis: An Important Mediator of Thrombus Formation and Cardiovascular Risk.
J Am Coll Cardiol. 2015 Apr 28;65(16):1683-1699. doi: 10.1016/j.jacc.2015.02.040.
5
Platelets and coagulation in thrombus formation: aberrations in the Scott syndrome.
Thromb Res. 2016 May;141 Suppl 2:S12-6. doi: 10.1016/S0049-3848(16)30355-3.
6
Branched-Chain Amino Acid Catabolism Promotes Thrombosis Risk by Enhancing Tropomodulin-3 Propionylation in Platelets.
Circulation. 2020 Jul 7;142(1):49-64. doi: 10.1161/CIRCULATIONAHA.119.043581. Epub 2020 Mar 23.
8
NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis.
Haematologica. 2018 Sep;103(9):1568-1576. doi: 10.3324/haematol.2018.191700. Epub 2018 May 24.
9
Curcumin, hemostasis, thrombosis, and coagulation.
J Cell Physiol. 2018 Jun;233(6):4497-4511. doi: 10.1002/jcp.26249. Epub 2017 Dec 26.
10
Haemostatic changes and the oral contraceptive pill.
Baillieres Clin Obstet Gynaecol. 1997 Sep;11(3):545-64. doi: 10.1016/s0950-3552(97)80027-2.

引用本文的文献

1
Berberine Targets PKM2 to Activate the t-PA-Induced Fibrinolytic System and Improves Thrombosis.
Pharmaceuticals (Basel). 2024 Sep 17;17(9):1219. doi: 10.3390/ph17091219.
2
A Novel Pathway of Platelet Activation in ACS Mediated by LL-37 Immunoglobulin G Autoantibody Immune Complexes.
JACC Basic Transl Sci. 2024 Jul 22;9(7):877-887. doi: 10.1016/j.jacbts.2024.04.012. eCollection 2024 Jul.
3
Causal association between cardiovascular proteins and membranous nephropathy: a bidirectional Mendelian randomization.
Int Urol Nephrol. 2024 Aug;56(8):2705-2714. doi: 10.1007/s11255-024-04004-w. Epub 2024 Mar 17.
4
Effectiveness of high flow nasal cannula oxygen therapy in patients of acute pulmonary thromboembolism with acute hypoxemic respiratory failure.
Med J Armed Forces India. 2022 Oct;78(4):448-453. doi: 10.1016/j.mjafi.2021.03.014. Epub 2021 May 26.
5
Management of Anticoagulation during Extracorporeal Membrane Oxygenation in Children.
Pediatr Rep. 2022 Jul 11;14(3):320-332. doi: 10.3390/pediatric14030039.
6
Changes of new coagulation markers in healthy pregnant women and establishment of reference intervals in Changsha.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Apr 28;47(4):469-478. doi: 10.11817/j.issn.1672-7347.2022.210536.
7
Global thrombosis test for assessing thrombotic status and efficacy of antithrombotic diet and other conditions.
Future Sci OA. 2022 Jan 31;8(3):FSO788. doi: 10.2144/fsoa-2021-0086. eCollection 2022 Mar.
8
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.
Angiogenesis. 2021 Nov;24(4):755-788. doi: 10.1007/s10456-021-09805-6. Epub 2021 Jun 28.
9
Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy.
Front Mol Biosci. 2021 May 28;8:680397. doi: 10.3389/fmolb.2021.680397. eCollection 2021.
10
Preclinical Evaluation of Safety and Biodistribution of Red Cell Microparticles: A Novel Hemostatic Agent.
J Cardiovasc Pharmacol Ther. 2019 Sep;24(5):474-483. doi: 10.1177/1074248419838512. Epub 2019 Apr 29.

本文引用的文献

3
Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.
Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):365-373. doi: 10.1161/ATVBAHA.116.308253. Epub 2016 Dec 29.
4
Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention.
Thromb Haemost. 2017 Feb 28;117(3):457-470. doi: 10.1160/TH16-09-0712. Epub 2015 Dec 22.
6
Platelet Activation: The Mechanisms and Potential Biomarkers.
Biomed Res Int. 2016;2016:9060143. doi: 10.1155/2016/9060143. Epub 2016 Jun 15.
10
Global and regional patterns in cardiovascular mortality from 1990 to 2013.
Circulation. 2015 Oct 27;132(17):1667-78. doi: 10.1161/CIRCULATIONAHA.114.008720.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验